K-Balo Tablet (Pitavastatin Calcium Hydrate)

Adult dose

In adults, the usual initial dose is 1 to 2 mg of pitavastatin calcium taken once daily. If the effect on lowering LDL cholesterol is insufficient, the dose may be increased up to a maximum of 4 mg per day. The dose may be appropriately adjusted at intervals of four weeks or more based on LDL cholesterol levels, treatment goals, and patient response, and the therapeutic effect of this medication is maintained with continuous use.

This medication is used for the treatment of hypercholesterolemia, and it should be avoided in certain patients. Patients who have had allergic reactions to this medication's components or those with active liver disease, severe liver impairment, or biliary obstruction should not use this drug. Additionally, it is not to be administered to patients taking cyclosporine, those with myopathy, pregnant women or women who may become pregnant, breastfeeding mothers, or children. Patients with impaired kidney function or a history of liver disease, as well as individuals consuming excessive alcohol, should use this medication with caution. Particularly, caution is needed when used concurrently with fibrate medications or niacin, as muscle damage and renal function deterioration may occur. During treatment with this medication, if symptoms such as muscle pain, weakness, or changes in urine color appear, consult a doctor immediately. Regular testing is necessary as liver function abnormalities or abnormalities in blood tests may be detected. Rarely, side effects such as skin rash, itching, headache, indigestion, and thrombocytopenia may occur. Elderly patients are at higher risk for side effects, so dosage adjustments and monitoring are necessary. Pregnant or breastfeeding women should not take it, as it may be harmful to the fetus or baby. The safety and efficacy of this drug in children have not been established. There may be interactions with other drugs, so especially if taking cyclosporine, fibrate medications, niacin, or erythromycin, it is essential to inform your doctor. This medication should be kept out of the reach of children and stored in its original container, and it should not be transferred to other containers arbitrarily. It is advisable to combine dietary and exercise regimens prior to taking this medication, and if there is no therapeutic effect, discontinue use.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, cough with accompanied fever and respiratory distress, yellowing of the skin or eyes (jaundice), extreme fatigue, sudden and severe headaches, lightning headache, seizures, confusion of consciousness, vision abnormalities, paralysis, urination.

Mild side effects

• Abdominal pain
• rash
• malaise
• paralysis
• itching
• myalgia
• weakness
• stiffness
• drowsiness
• insomnia

This medication should be stored in special containers to prevent light and air from entering. The storage temperature should be maintained at room temperature between 1 to 30 degrees Celsius.

Appearance

Very light yellowish-red round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle